Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Patients, farmers and advocates urge CRC to protect medical program and increase market transparency

New Jersey Cannabis Regulatory Commission · February 20, 2026
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

During public comment at the CRC special meeting, multiple speakers warned that medical patient enrollment is falling, urged protections for medical access and product diversity, and called for stronger transparency and enforcement against gray‑market products and large alleged illegal grows.

Public speakers used the commission’s special meeting to press the New Jersey Cannabis Regulatory Commission on three related themes: reviving the medical cannabis program, improving market transparency and data (including public Certificates of Analysis), and investigating alleged large illegal grows and cross‑border or untested products.

Michelle (Nichelle) Santos, speaking as a concerned consumer, said the state’s medical program is losing patients to the adult‑use market and that ‘‘for these individuals, cannabis is not a consumer product. It’s a medicine.’’ She urged the commission to modernize the medical program by incentivizing medical‑grade product diversity, requiring certified medical…

Already have an account? Log in

Subscribe to keep reading

Unlock the rest of this article — and every article on Citizen Portal.

  • Unlimited articles
  • AI-powered breakdowns of topics, speakers, decisions, and budgets
  • Instant alerts when your location has a new meeting
  • Follow topics and more locations
  • 1,000 AI Insights / month, plus AI Chat
30-day money-back on paid plans